Your GP may arrange further blood tests, imaging studies, or referral to specialist services depending on clinical suspicion and initial investigation results
Assuming that the percentage of patients showing an increase in serum vitamin B12 concentration to above 179 pg/ml in both groups is 70%, means the study requires at least 304 patients (152 in each arm) for a threshold of non-inferiority of 10% and a statistical power of 60% with significance set at p 179 pg/ml: patient preference questionnaire Randomisation of patients to treatment group Visit 1 (start of treatment) Anamnesis: record whether the patient lives alone or with others, lifestyle habits, use of alcohol, whether a vegan diet is followed, whether the patient has undergone gastrectomy Symptoms: record paresthesia, asthenia, loss or reduction of appetite, sadness or change in state of mind, concomitant pharmacological treatment Physical examination: for Hunters glositis, positional and vibrational sensitivity Questionnaires: Lobo cognitive mini-exam, EuroQoL-5D Record concomitant treatment Request analyses to be performed one week before next visit: haemogram and serum vitamin B12 Therapeutic plan: patient in oral arm provision of medication
However, it is important to understand that 24 weeks, while substantial for clinical trials, provides limited information about safety with years-long continuous use
For patients who experience a sustained increase in resting heart rate while taking semaglutide, the drug should be discontinued
At the moment, there is insufficient evidence for these sport performance outcomes in humans
Our evidence-based IV formulas provide fluids, electrolytes, and essential nutrients, with optional add-ons like antioxidants and longevity-focused compounds, all thoughtfully tailored to your bodys needs
